Recipient
Virica Biotech Inc.Department
National Research Council CanadaAmount
$75.0K
Province
ONType
Contribution
Agreement Number
172-2025-2026-Q3-1037431
Purpose
In this project Virica Biotech (TM) will develop custom VSE (TM) enhancer formulations and optimize parameters for AAV vector production in Japanese Partner proprietary media, feed, and cells to create a joint offering for international academic and commercial clients. Virica will apply internal expertise, including high-throughput viral production/quantification assays and Design of Experiment frameworks, to enable simultaneous optimization of multiple factors and VSE candidates.
Virica Biotech Inc. × National Research Council Canada
12 grants totalling $1.3M
Industrial Research Assistance Program – Contributions to Firms
26,784 grants totalling $5.1B
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| Entos Pharmaceuticals Inc. | $10.0M | Industrial Research Assistance Program –... |
| ILLUMIN INC. | $10.0M | Industrial Research Assistance Program –... |